Beruflich Dokumente
Kultur Dokumente
(HTTP://WELLMETRIS.COM)
related diseases such as cardiovascular disease, diabetes, and some cancers. Furthermore, research indicates that metabolomics may be a key element in improving
early diagnosis of diseases and accuracy of disease prognosis. It may also provide advantages in terms of monitoring diseases and determining early markers of damage
to certain organs. Human-nutrition metabolomics has provided valuable insight on nutrient interactions with metabolism, as well as insight on the potential for
metabolic alteration as a therapeutic intervention for improving health.5
WellMetris Wellness Pro le
At WellMetris, we have designed the Wellness Pro le, which capitalizes on the potential advantages of metabolomics for assessing health and wellness. Our noninvasive urinalysis system measures speci c biomarkers that are related to oxidative stress, in ammatory status, and antioxidant capacity. Our goal is to provide
employers, insurers, providers, and end-users with valuable information to optimize health, wellness, and nancial decision-making.
Sources:
1. http://isaaa.org/resources/publications/pocketk/15/ (http://isaaa.org/resources/publications/pocketk/15/)
2. http://genomemedicine.com/content/5/6/58 (http://genomemedicine.com/content/5/6/58)
3. Donna L. Mendrick&Laura Schnackenberg, Genomic and metabolomic advances in the identi cation of disease and adverse event biomarkers, Biomarkers in Medicine
(http://www.futuremedicine.com/loi/bmm) October 2009, Vol. 3, No. 5, Pages 605-615.
4. Emily G. Armitage, Francisco J. Ruprez, Coral Barbas, Metabolomics of diet-related diseases using mass spectrometry, TrAC Trends in Analytical Chemistry, Volume 52,
December 2013, Pages 61-73, ISSN 0165-9936, http://dx.doi.org/10.1016/j.trac.2013.08.003 (http://dx.doi.org/10.1016/j.trac.2013.08.003).
(http://www.sciencedirect.com/science/article/pii/S0165993613001970 (http://www.sciencedirect.com/science/article/pii/S0165993613001970)) (citing: A. Nordstrom, R.
Lewensohn, Journal of Neuroimmune Pharmacology 5(2010) 4.; ] A. DAlessandro, B. Giardina, F. Gevi, A.M. Timperio, L. Zolla, Blood Transfusion 10 (2012) S19; I.
Kouskoumvekaki, G. Panagiotou, Journal of Biomedicine and Biotechnology2001 (2011); A. Zhang, H. Sun, X. Wang, Analytical and Bioanalytical Chemistry 404 (2012) 1239; M.
Mamas, W.B. Dunn, L. Neyses, R. Goodacre, Archives of Toxicology 85(2011) 5; N.S. Fearnhead, J.L. Wilding, W.F. Bodmer, British Medical Bulletin 64 (2002)).
5. See source 4. (citing: M. Oresic, Nutrition Metabolism and Cardiovascular Diseases 19 (2009) 816.; C. Manach, J. Hubert, R. Llorach, A. Scalbert, Molecular Nutrition & Food
Research 53 (2009) 1303.)
(http://ww
2013 WellMetris